188 related articles for article (PubMed ID: 29197096)
1. Observations on the origin of ovarian cortical inclusion cysts in women undergoing risk-reducing salpingo-oophorectomy.
Park KJ; Patel P; Linkov I; Jotwani A; Kauff N; Pike MC
Histopathology; 2018 Apr; 72(5):766-776. PubMed ID: 29197096
[TBL] [Abstract][Full Text] [Related]
2. Two types of ovarian cortical inclusion cysts: proposed origin and possible role in ovarian serous carcinogenesis.
Banet N; Kurman RJ
Int J Gynecol Pathol; 2015 Jan; 34(1):3-8. PubMed ID: 25473746
[TBL] [Abstract][Full Text] [Related]
3. Impact and mechanistic role of oral contraceptive pills on the number and epithelial type of ovarian cortical inclusion cysts; a clinicopathology and immunohistochemical study.
DastranjTabrizi A; MostafaGharabaghi P; SheikhzadehHesari F; Sadeghi L; Zamanvandi S; Sarbakhsh P; Ghojazadeh M
Diagn Pathol; 2016 Mar; 11():30. PubMed ID: 27000861
[TBL] [Abstract][Full Text] [Related]
4. [Origin of ovarian epithelial inclusions and its relationship with the development of low-grade serous carcinoma].
Xiang L; Li J; Wang LJ; Zheng WX; Kong BH
Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):729-35. PubMed ID: 22321344
[TBL] [Abstract][Full Text] [Related]
5. Proliferation of the Fallopian Tube Fimbriae and Cortical Inclusion Cysts: Effects of the Menstrual Cycle and the Levonorgestrel Intrauterine Contraceptive System.
Park KJ; Broach V; Chi DS; Linkov I; Stanczyk FZ; Patel P; Jotwani A; Pearce CL; Pike MC; Kauff ND
Cancer Epidemiol Biomarkers Prev; 2022 Sep; 31(9):1823-1829. PubMed ID: 35700017
[TBL] [Abstract][Full Text] [Related]
6. Tubal origin of 'ovarian' low-grade serous carcinoma.
Li J; Abushahin N; Pang S; Xiang L; Chambers SK; Fadare O; Kong B; Zheng W
Mod Pathol; 2011 Nov; 24(11):1488-99. PubMed ID: 21701538
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal to epithelial transition in the human ovarian surface epithelium focusing on inclusion cysts.
Okamoto S; Okamoto A; Nikaido T; Saito M; Takao M; Yanaihara N; Takakura S; Ochiai K; Tanaka T
Oncol Rep; 2009 May; 21(5):1209-14. PubMed ID: 19360296
[TBL] [Abstract][Full Text] [Related]
8. Expression of candidate tumor markers in ovarian carcinoma and benign ovary: evidence for a link between epithelial phenotype and neoplasia.
Drapkin R; Crum CP; Hecht JL
Hum Pathol; 2004 Aug; 35(8):1014-21. PubMed ID: 15297969
[TBL] [Abstract][Full Text] [Related]
9. Epidemiologic correlates of ovarian cortical inclusion cysts (CICs) support a dual precursor pathway to pelvic epithelial cancer.
Folkins AK; Saleemuddin A; Garrett LA; Garber JE; Muto MG; Tworoger SS; Crum CP
Gynecol Oncol; 2009 Oct; 115(1):108-111. PubMed ID: 19615727
[TBL] [Abstract][Full Text] [Related]
10. A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations.
Folkins AK; Jarboe EA; Saleemuddin A; Lee Y; Callahan MJ; Drapkin R; Garber JE; Muto MG; Tworoger S; Crum CP
Gynecol Oncol; 2008 May; 109(2):168-73. PubMed ID: 18342932
[TBL] [Abstract][Full Text] [Related]
11. PAX8 expression in ovarian surface epithelial cells.
Adler E; Mhawech-Fauceglia P; Gayther SA; Lawrenson K
Hum Pathol; 2015 Jul; 46(7):948-56. PubMed ID: 26079312
[TBL] [Abstract][Full Text] [Related]
12. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
13. PAX8: a sensitive and specific marker to identify cancer cells of ovarian origin for patients prior to neoadjuvant chemotherapy.
Wang Y; Wang Y; Li J; Yuan Z; Yuan B; Zhang T; Cragun JM; Kong B; Zheng W
J Hematol Oncol; 2013 Aug; 6():60. PubMed ID: 23958394
[TBL] [Abstract][Full Text] [Related]
14. Pathology of ovarian cancer precursors.
Scully RE
J Cell Biochem Suppl; 1995; 23():208-18. PubMed ID: 8747398
[TBL] [Abstract][Full Text] [Related]
15. Lineage tracing suggests that ovarian endosalpingiosis does not result from escape of oviductal epithelium.
Wang Y; Sessine MS; Zhai Y; Tipton C; McCool K; Kuick R; Connolly DC; Fearon ER; Cho KR
J Pathol; 2019 Oct; 249(2):206-214. PubMed ID: 31131879
[TBL] [Abstract][Full Text] [Related]
16. The origin of ovarian carcinomas: a unifying hypothesis.
Auersperg N
Int J Gynecol Pathol; 2011 Jan; 30(1):12-21. PubMed ID: 21131839
[TBL] [Abstract][Full Text] [Related]
17. Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium.
Rodgers LH; Ó hAinmhire E; Young AN; Burdette JE
Oncotarget; 2016 May; 7(22):32785-95. PubMed ID: 27129161
[TBL] [Abstract][Full Text] [Related]
18. Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women With BRCA mutations.
Rabban JT; Crawford B; Chen LM; Powell CB; Zaloudek CJ
Am J Surg Pathol; 2009 Jan; 33(1):111-9. PubMed ID: 18830124
[TBL] [Abstract][Full Text] [Related]
19. Challenging Salpingectomy as a Risk-Reducing Measure for Ovarian Cancer: Histopathological Analysis of the Tubo-Ovarian Interface in Women Undergoing Risk-Reducing Salpingo-oophorectomy.
Ayres C; Ratnayake G; McNally O; Quinn M
Int J Gynecol Cancer; 2017 May; 27(4):703-707. PubMed ID: 28399030
[TBL] [Abstract][Full Text] [Related]
20. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC
Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]